Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC
Public ClinicalTrials.gov record NCT01673867. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Randomized Phase III Trial of BMS-936558 (Nivolumab) Versus Docetaxel in Previously Treated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to compare the overall survival of BMS-936558 (Nivolumab) as compared with Docetaxel in subjects with non-squamous cell non-small cell lung cancer (NSCLC) after failure of prior platinum-based chemotherapy
Study identification
- NCT ID
- NCT01673867
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 582 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2, 2012 (Actual)
- Primary completion
- Feb 5, 2015 (Actual)
- Completion
- Dec 17, 2021 (Actual)
- Last update posted
- Feb 8, 2023
2012 – 2021
United States locations
- U.S. sites
- 30
- U.S. states
- 18
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Arizona | Scottsdale | Arizona | 85259 | — |
| Local Institution - 0009 | Duarte | California | 91010 | — |
| Local Institution - 0042 | San Diego | California | 92123 | — |
| San Francisco Oncology Associates | San Francisco | California | 94115 | — |
| Yale University | New Haven | Connecticut | 06520 | — |
| Local Institution - 0034 | Tampa | Florida | 33612 | — |
| Northwest Georgia Oncology Center, P.C. | Marietta | Georgia | 30060 | — |
| Local Institution - 0030 | Chicago | Illinois | 60637 | — |
| The Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Local Institution - 0031 | Boston | Massachusetts | 02215 | — |
| Local Institution - 0040 | Boston | Massachusetts | 02215 | — |
| Local Institution - 0138 | Boston | Massachusetts | 02215 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Local Institution - 0008 | Mineola | New York | 11501 | — |
| Local Institution - 0020 | New York | New York | 10065 | — |
| Local Institution - 0027 | Durham | North Carolina | 27710 | — |
| Local Institution - 0026 | Cincinnati | Ohio | 45242 | — |
| St. Mary Medical Center | Langhorne | Pennsylvania | 19047 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| Local Institution - 0035 | Sayre | Pennsylvania | 18840 | — |
| Local Institution - 0025 | Columbia | South Carolina | 29210 | — |
| Local Institution - 0024 | Chattanooga | Tennessee | 37404 | — |
| Local Institution - 0028 | Nashville | Tennessee | 37203 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Local Institution - 0033 | Dallas | Texas | 75390 | — |
| Local Institution - 0032 | Houston | Texas | 77030 | — |
| Local Institution - 0041 | Kennewick | Washington | 99336 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
| Local Institution - 0007 | Seattle | Washington | 98109 | — |
| Local Institution - 0019 | Morgantown | West Virginia | 26506-9162 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 89 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01673867, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2023 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01673867 live on ClinicalTrials.gov.